文献速递消化内镜消化道肿瘤与早癌

新型远端附件装置辅助结肠镜提高腺瘤检出率的前瞻性随机对照试验

Improved adenoma detection by a novel distal attachment device-assisted colonoscopy: a prospective randomized controlled trial.
PubMed 文献 · Gastrointest Endosc · 2022-04-30

这项单中心前瞻性随机对照试验将537例门诊结肠镜检查患者随机分为WingCap辅助组与标准结肠镜组,比较腺瘤检出率(ADR)和每结肠镜腺瘤数(APC)。WingCap组ADR显著高于对照组(37.2% vs 26.6%,P=.012),APC也更多(0.72±1.34 vs 0.45±0.97,P=.008),尤其对无蒂和小腺瘤以及初学者内镜医师效果更明显。两组盲肠插管时间和退镜时间无差异,无严重不良事件。

要点

  • WingCap辅助结肠镜的ADR显著高于标准结肠镜(37.2% vs 26.6%,P=.012)。
  • WingCap组APC更多(0.72±1.34 vs 0.45±0.97,P=.008),无蒂和小腺瘤更明显。
  • 初学者内镜医师使用WingCap后ADR和APC显著增加,经验丰富者仅小幅增加。

核心结论

  • WingCap辅助结肠镜耐受性良好,与标准结肠镜相比可有效提高ADR和APC,尤其对无蒂和小腺瘤以及初学者内镜医师。

研究设计与样本

  • 单中心、前瞻性、随机对照试验,纳入年龄≥18岁接受结肠镜检查的门诊患者,共537例随机分入WingCap辅助组或标准结肠镜组。
  • 主要结局为WingCap辅助下的ADR差异,次要结局为APC及盲肠插管时间、退镜时间等其他结肠镜质量指标。

主要发现

  • WingCap组ADR显著高于对照组(37.2% vs 26.6%,P=.012)。
  • WingCap组APC大于标准结肠镜组(0.72±1.34 vs 0.45±0.97,P=.008)。
  • 无蒂腺瘤APC在WingCap组更高(0.65±1.25 vs 0.42±0.95,P=.015)。
  • 小腺瘤APC在WingCap组更高(0.42±0.94 vs 0.20±0.64,P=.002)。
  • 初学者内镜医师使用WingCap后ADR和APC显著增加,经验丰富者仅小幅增加;两组盲肠插管时间和退镜时间无差异,无与WingCap使用相关的严重不良事件。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: WingCap (A&A Medical Supply LLC, Seongnam, South Korea) is a novel distal attachment device for colonoscopy that combines a cap and an existing mucosal exposure device, such as Endocuff Vision (Arc Medical Design Ltd, Leeds, UK) and AmplifEYE (Medivators Inc, Minneapolis, Minn, USA). We aimed to investigate whether WingCap-assisted colonoscopy can improve the adenoma detection rate (ADR) and adenoma per colonoscopy (APC) and simultaneously shorten cecal intubation time compared with standard colonoscopy. METHODS: We conducted a single-center, prospective, randomized controlled trial for outpatients aged ≥18 years undergoing colonoscopy. The primary outcome was ADR differences with the assistance of WingCap. Secondary outcomes were APC and other colonoscopy quality indicators, such as cecal intubation and withdrawal times. RESULTS: In total, 537 patients were randomized for WingCap-assisted or standard colonoscopy. Their mean age was 59.3 years, and 48.5% were men. ADR was significantly higher in the WingCap group than in the control group (37.2% vs 26.6%, P = .012). APC was greater with WingCap than with standard colonoscopy (.72 ± 1.34 vs .45 ± 0.97, P = .008), prominently for nonpedunculated (.65 ± 1.25 vs .42 ± .95, P = .015) and diminutive (.42 ± .94 vs .20 ± .64, P = .002) adenomas. With WingCap, ADR and APC significantly increased for beginner endoscopists, whereas a modest increase was seen for experienced endoscopists. There were no differences in cecal intubation and withdrawal times between the 2 arms. No serious adverse event was associated with the use of WingCap. CONCLUSIONS: WingCap-assisted colonoscopy was tolerable and efficacious for improving ADR and APC compared with standard colonoscopy, especially for nonpedunculated and diminutive adenomas and for beginner endoscopists. (Clinical trial registration number: KCT0005214.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Hong SW, Hong HS, Kim K, et al. Improved adenoma detection by a novel distal attachment device-assisted colonoscopy: a prospective randomized controlled trial. Gastrointest Endosc. 2022. PMID: 35500658. doi:10.1016/j.gie.2022.04.1307

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。